A genome-wide association search for type 2 diabetes genes in African Americans.
Palmer ND., McDonough CW., Hicks PJ., Roh BH., Wing MR., An SS., Hester JM., Cooke JN., Bostrom MA., Rudock ME., Talbert ME., Lewis JP., DIAGRAM Consortium None., MAGIC Investigators None., Ferrara A., Lu L., Ziegler JT., Sale MM., Divers J., Shriner D., Adeyemo A., Rotimi CN., Ng MCY., Langefeld CD., Freedman BI., Bowden DW., Voight BF., Scott LJ., Steinthorsdottir V., Morris AP., Dina C., Welch RP., Zeggini E., Huth C., Aulchenko YS., Thorleifsson G., McCulloch LJ., Ferreira T., Grallert H., Amin N., Wu G., Willer CJ., Raychaudhuri S., McCarroll SA., Langenberg C., Hofmann OM., Dupuis J., Qi L., Segrè AV., van Hoek M., Navarro P., Ardlie K., Balkau B., Benediktsson R., Bennett AJ., Blagieva R., Boerwinkle E., Bonnycastle LL., Boström KB., Bravenboer B., Bumpstead S., Burtt NP., Charpentier G., Chines PS., Cornelis M., Couper DJ., Crawford G., Doney ASF., Elliott KS., Elliott AL., Erdos MR., Fox CS., Franklin CS., Ganser M., Gieger C., Grarup N., Green T., Griffin S., Groves CJ., Guiducci C., Hadjadj S., Hassanali N., Herder C., Isomaa B., Jackson AU., Johnson PRV., Jørgensen T., Kao WHL., Klopp N., Kong A., Kraft P., Kuusisto J., Lauritzen T., Li M., Lieverse A., Lindgren CM., Lyssenko V., Marre M., Meitinger T., Midthjell K., Morken MA., Narisu N., Nilsson P., Owen KR., Payne F., Perry JRB., Petersen A-K., Platou C., Proença C., Prokopenko I., Rathmann W., Rayner NW., Robertson NR., Rocheleau G., Roden M., Sampson MJ., Saxena R., Shields BM., Shrader P., Sigurdsson G., Sparsø T., Strassburger K., Stringham HM., Sun Q., Swift AJ., Thorand B., Tichet J., Tuomi T., van Dam RM., van Haeften TW., van Herpt T., van Vliet-Ostaptchouk JV., Walters GB., Weedon MN., Wijmenga C., Witteman J., Bergman RN., Cauchi S., Collins FS., Gloyn AL., Gyllensten U., Hansen T., Hide WA., Hitman GA., Hofman A., Hunter DJ., Hveem K., Laakso M., Mohlke KL., Morris AD., Palmer CNA., Pramstaller PP., Rudan I., Sijbrands E., Stein LD., Tuomilehto J., Uitterlinden A., Walker M., Wareham NJ., Watanabe RM., Abecasis GR., Boehm BO., Campbell H., Daly MJ., Hattersley AT., Hu FB., Meigs JB., Pankow JS., Pedersen O., Wichmann H-E., Barroso I., Florez JC., Frayling TM., Groop L., Sladek R., Thorsteinsdottir U., Wilson JF., Illig T., Froguel P., van Duijn CM., Stefansson K., Altshuler D., Boehnke M., McCarthy MI., Soranzo N., Wheeler E., Glazer NL., Bouatia-Naji N., Mägi R., Randall J., Johnson T., Elliott P., Rybin D., Henneman P., Dehghan A., Hottenga JJ., Song K., Goel A., Egan JM., Lajunen T., Doney A., Kanoni S., Cavalcanti-Proença C., Kumari M., Timpson NJ., Zabena C., Ingelsson E., An P., O'Connell J., Luan J., Elliott A., McCarroll SA., Roccasecca RM., Pattou F., Sethupathy P., Ariyurek Y., Barter P., Beilby JP., Ben-Shlomo Y., Bergmann S., Bochud M., Bonnefond A., Borch-Johnsen K., Böttcher Y., Brunner E., Bumpstead SJ., Chen Y-DI., Chines P., Clarke R., Coin LJM., Cooper MN., Crisponi L., Day INM., de Geus EJC., Delplanque J., Fedson AC., Fischer-Rosinsky A., Forouhi NG., Frants R., Franzosi MG., Galan P., Goodarzi MO., Graessler J., Grundy S., Gwilliam R., Hallmans G., Hammond N., Han X., Hartikainen A-L., Hayward C., Heath SC., Hercberg S., Hicks AA., Hillman DR., Hingorani AD., Hui J., Hung J., Jula A., Kaakinen M., Kaprio J., Kesaniemi YA., Kivimaki M., Knight B., Koskinen S., Kovacs P., Kyvik KO., Lathrop GM., Lawlor DA., Le Bacquer O., Lecoeur C., Li Y., Mahley R., Mangino M., Manning AK., Martínez-Larrad MT., McAteer JB., McPherson R., Meisinger C., Melzer D., Meyre D., Mitchell BD., Mukherjee S., Naitza S., Neville MJ., Oostra BA., Orrù M., Pakyz R., Paolisso G., Pattaro C., Pearson D., Peden JF., Pedersen NL., Perola M., Pfeiffer AFH., Pichler I., Polasek O., Posthuma D., Potter SC., Pouta A., Province MA., Psaty BM., Rayner NW., Rice K., Ripatti S., Rivadeneira F., Rolandsson O., Sandbaek A., Sandhu M., Sanna S., Sayer AA., Scheet P., Seedorf U., Sharp SJ., Shields B., Sijbrands EJG., Silveira A., Simpson L., Singleton A., Smith NL., Sovio U., Swift A., Syddall H., Syvänen A-C., Tanaka T., Tönjes A., Uitterlinden AG., van Dijk KW., Varma D., Visvikis-Siest S., Vitart V., Vogelzangs N., Waeber G., Wagner PJ., Walley A., Ward KL., Watkins H., Wild SH., Willemsen G., Witteman JCM., Yarnell JWG., Zelenika D., Zethelius B., Zhai G., Zhao JH., Zillikens MC., Borecki IB., Loos RJF., Meneton P., Magnusson PKE., Nathan DM., Williams GH., Silander K., Salomaa V., Smith GD., Bornstein SR., Schwarz P., Spranger J., Karpe F., Shuldiner AR., Cooper C., Dedoussis GV., Serrano-Ríos M., Lind L., Palmer LJ., Franks PW., Ebrahim S., Marmot M., Kao WHL., Pramstaller PP., Wright AF., Stumvoll M., Hamsten A., Buchanan TA., Valle TT., Rotter JI., Siscovick DS., Penninx BWJH., Boomsma DI., Deloukas P., Spector TD., Ferrucci L., Cao A., Scuteri A., Schlessinger D., Uda M., Ruokonen A., Jarvelin M-R., Waterworth DM., Vollenweider P., Peltonen L., Mooser V., Sladek R.
African Americans are disproportionately affected by type 2 diabetes (T2DM) yet few studies have examined T2DM using genome-wide association approaches in this ethnicity. The aim of this study was to identify genes associated with T2DM in the African American population. We performed a Genome Wide Association Study (GWAS) using the Affymetrix 6.0 array in 965 African-American cases with T2DM and end-stage renal disease (T2DM-ESRD) and 1029 population-based controls. The most significant SNPs (n = 550 independent loci) were genotyped in a replication cohort and 122 SNPs (n = 98 independent loci) were further tested through genotyping three additional validation cohorts followed by meta-analysis in all five cohorts totaling 3,132 cases and 3,317 controls. Twelve SNPs had evidence of association in the GWAS (P<0.0071), were directionally consistent in the Replication cohort and were associated with T2DM in subjects without nephropathy (P<0.05). Meta-analysis in all cases and controls revealed a single SNP reaching genome-wide significance (P<2.5×10(-8)). SNP rs7560163 (P = 7.0×10(-9), OR (95% CI) = 0.75 (0.67-0.84)) is located intergenically between RND3 and RBM43. Four additional loci (rs7542900, rs4659485, rs2722769 and rs7107217) were associated with T2DM (P<0.05) and reached more nominal levels of significance (P<2.5×10(-5)) in the overall analysis and may represent novel loci that contribute to T2DM. We have identified novel T2DM-susceptibility variants in the African-American population. Notably, T2DM risk was associated with the major allele and implies an interesting genetic architecture in this population. These results suggest that multiple loci underlie T2DM susceptibility in the African-American population and that these loci are distinct from those identified in other ethnic populations.